STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow STE
STERIS plc (STE) EV/FCF
As of 16 October 2026, STERIS plc (STE) trades at a EV/FCF of 24.7×. Over the past ten years it has ranged from 15.5× (June 2015) to 68.7× (April 2022); the current reading is higher than 13% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2026 | 23.6× | (23.26%) |
| FY2025 | 30.8× | (23.15%) |
| FY2024 | 40.0× | (25.27%) |
| FY2023 | 53.6× | (18.79%) |
| FY2022 | 66.0× | 68.24% |
| FY2021 | 39.2× | 17.23% |
| FY2020 | 33.4× | 1.24% |
| FY2019 | 33.0× | 9.81% |
| FY2018 | 30.1× | 8.00% |
| FY2017 | 27.9× | (43.29%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 23.5× | (0.62%) |
| Mar 2026 | 23.6× | (16.53%) |
| Dec 2025 | 28.3× | 5.36% |
| Sep 2025 | 26.8× | (2.91%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 7.7× |
| GMED Globus Medical, Inc. compare | 14.4× |
| PHG Koninklijke Philips N.V. compare | 16.1× |
| DXCM DexCom, Inc. compare | 23.5× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 24.4× |
| STE STERIS plc | 24.7× |
| GEHC GE HealthCare Technologies Inc. compare | 25.9× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 26.3× |
| PEN Penumbra, Inc. compare | 55.5× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement